GlassScriptPhysician profile
Amish J Desai
NPI 1134282932
$186,114.32
in general payments reported to CMS, 2019-2025
28 companies · $15K in 2025
The $15K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $44K · 2021: $23K · 2022: $27K · 2023: $12K · 2024: $41K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Consulting Fee: $21K · Food and Beverage: $11K · Travel and Lodging: $5,604 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,000.00 |
| Consulting Fee | $20,750.00 |
| Food and Beverage | $11,487.32 |
| Travel and Lodging | $5,604.39 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $172,376.73 | 2019-2025 | Watchman Access System, Watchman Flx, Avvigo Guidance System |
| Edwards Lifesciences Corporation | $8,121.54 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Abiomed | $2,326.13 | 2019-2025 | Impella |
| Abbott Laboratories | $1,580.44 | 2019-2025 | Amplatzer Amulet, Navitor, Amplatzer |
| Shockwave Medical, INC | $487.93 | 2020-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $170.80 | 2019-2025 | Lifevest |
| Philips North America LLC | $147.85 | 2019-2024 | (Ao0) Igt Devices Intracardiac |
| Amag Pharmaceuticals, INC. | $86.63 | 2021 | |
| Endotronix, INC. | $83.17 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| E.R. Squibb & Sons, L.L.C. | $80.05 | 2019-2024 | Camzyos |
| Regeneron Healthcare Solutions, INC. | $66.40 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $65.26 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $63.91 | 2019 | |
| Amgen INC. | $62.01 | 2019-2023 | Repatha |
| Recor Medical INC | $53.94 | 2025 | Paradise Ultrasound Renal Denervation System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $46.93 | 2022-2023 | Farxiga |
| Pfizer INC. | $46.38 | 2023-2025 | |
| Teleflex LLC | $44.03 | 2023-2025 | Vascband, Guideliner |
| Acist Medical Systems, INC. | $37.57 | 2025 | |
| Merck Sharp & Dohme LLC | $31.61 | 2025 | Verquvo |
| W. L. Gore & Associates, INC. | $27.95 | 2025 | Gore Cardioform Septal Occluder |
| Cvrx, INC. | $24.96 | 2024 | Barostim Neo System |
| Heartflow, INC. | $21.48 | 2025 | |
| Chiesi USA, INC. | $16.15 | 2022 | |
| Cardiovascular Systems INC. | $15.92 | 2019 | |
| Catheter Precision INC. | $14.34 | 2024 | |
| Cordis US Corp. | $14.21 | 2025 | Mynx Control Venous |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amish Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.